Aetna CEO says no decision yet on how to cover hepatitis C drugs

Jan 13 (Reuters) - The chief executive of health insurer Aetna Inc on Tuesday said that the company had not yet decided which hepatitis C drugs to cover now that there are two breakthrough treatments on the market, but said that the company was actively working on a decision.